The Global Proteomics Market Report by The Business Research Company covers proteomics market drivers and restraints, proteomics market size, major players, and the impact of COVID-19 on the proteomics market.
The proteomics market consists of sales of proteomics and related goods. Proteomics is a study of the structure and functions of proteins that are used in drug discovery, diagnosis, and treatment of diseases. Proteomics is used to evaluate the protein production rate, the involvement of proteins in metabolic pathways, and modifications of proteins.
Rising government funds for research on proteomics drives the growth of the proteomics market. Government funds help researchers in drug discovery, diagnosis, and treatment of diseases.
The global proteomics market is expected to grow from $19.96 billion in 2020 to $22.61 billion in 2021 at a compound annual growth rate (CAGR) of 13.3%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The proteomics market is expected to reach $37.88 billion in 2025 at a CAGR of 14%.
Request A Sample For The Global Proteomics Market Report:
Some proteomics market trends include companies launching new products in order to increase their revenue and also gain a competitive edge over their rivals. For instance, in June 2018, Bruker Corporation, a USA-based scientific instruments manufacturing company, launched a wide range of mass spectrometry devices, such as scimaXTM Magnetic Resonance Mass Spectrometer (MRMS), which is designed for enabling high throughput. The MRMS has mass resolution exceeding 20 million, in a smaller footprint and without the need for any liquid cryogens. Using MRMS, Biopharma users can perform advanced native protein and fragment-based drug discovery studies, which has recently been called a “bona-fide” platform for native protein analysis in the scientific literature.
Global proteomics market segments include:
1) By Component: Reagents, Instruments.
2) By Instrument: Protein Microarrays, Spectroscopy, X-Ray Crystallography, Chromatography, Electrophoresis, Surface Plasmon Resonance, Protein Fractionation.
3) By Service and Software: Core Proteomics Services, Bioinformatics Software & Services.
By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read More On The Proteomics Global Market Report 2021: COVID-19 Growth And Change To 2030 At:
The Proteomics Global Market Report 2021: COVID-19 Growth And Change To 2030 is one of a series of new reports from The Business Research Company that provides proteomics market overviews, analyzes and forecasts market size, share, proteomics market players, proteomics market segments and geographies, market’s leading competitors’ revenues, profiles and market shares.
The proteomics market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Where To Learn More:
Read Proteomics Global Market Report 2021: COVID-19 Growth And Change To 2030 from The Business Research Company for information on the following:
Data Segmentations: Market Size, Global, By Region And By Country, Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries.
Market Players Covered: Thermo Fisher Scientific Inc., Agilent Technologies Inc., Danaher Corporation, Merck KGaA, Waters Corporation, Perkinelmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, GE Healthcare, Caprion Biosciences, Luminex Corporation, LI-COR Inc., Becton Dickinson and Company, Siemens Ltd, Genzyme Corporation, Creative Proteomics, Promega Corporation.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)
Other Information And Analyses: SWOT analysis, customer information, market product/service analysis – product examples, trends and opportunities, drivers and restraints, key mergers and acquisitions, suggested trend based strategies, impact of COVID-19 on the market, future outlook and potential analysis, key metrics covered: number of enterprises, number of employees, global market in 2021 – countries offering most new opportunities, conclusions and recommendations by expert analysts.
Sourcing And Referencing: Data and analysis throughout the report are sourced using end notes.
Strategies For Participants In The proteomics Industry: The report explains a number of strategies for companies in the market, based on industry trends and company analysis.
Opportunities For Companies In The proteomics Sector: The report reveals where the global industry will put on most $ sales up to 2023.
Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
Here is a list of reports from The Business Research Company similar to the Proteomics Global Market Report 2021:
CAR-T Therapy Market – By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies – Global Forecast To 2030